Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;1482(1):26-35.
doi: 10.1111/nyas.14467. Epub 2020 Sep 6.

Do we understand the pathophysiology of GERD after sleeve gastrectomy?

Affiliations
Review

Do we understand the pathophysiology of GERD after sleeve gastrectomy?

Eleni Felinska et al. Ann N Y Acad Sci. 2020 Dec.

Abstract

Gastroesophageal reflux disease (GERD), a prevalent problem among obese individuals, is strongly associated with obesity and weight loss. Hence, bariatric surgery effectively improves GERD for many patients. Depending on the type of bariatric procedure, however, surgery can also worsen or even cause a new onset of GERD. As a consequence, GERD remains a relevant problem for many bariatric patients, and especially those who have undergone sleeve gastrectomy (SG). Affected patients report not only a decrease in physical functioning but also suffer from mental and emotional problems, resulting in poorer social functioning. The pathomechanism of GERD after SG is most likely multifactorial and triggered by the interaction of anatomical, physiological, and physical factors. Contributing factors include the shape of the sleeve, the extent of injury to the lower esophageal sphincter, and the presence of hiatal hernia. In order to successfully treat post-sleeve gastrectomy GERD, the cause of the problem must first be identified. Therapeutic approaches include lifestyle changes, medication, interventional treatment, and/or revisional surgery.

Keywords: bariatric surgery; gastroesophageal reflux; morbid obesity; sleeve gastrectomy.

PubMed Disclaimer

References

    1. Eusebi, L.H., R. Ratnakumaran, Y. Yuan, et al. 2018. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 67: 430-440.
    1. Vakil, N., S.V. van Zanten, P. Kahrilas, et al. 2006. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 101: 1900-1920; quiz 1943.
    1. Lenderking, W.R., E. Hillson, J.A. Crawley, et al. 2003. The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life. Value Health 6: 560-565.
    1. Qumseya, B.J., A. Bukannan, S. Gendy, et al. 2019. Systematic review and meta-analysis of prevalence and risk factors for Barrett's esophagus. Gastrointest. Endosc. 90: 707-717.e701.
    1. Findlay, J.M., M.R. Middleton & I. Tomlinson. 2016. Genetic biomarkers of Barrett's esophagus susceptibility and progression to dysplasia and cancer: a systematic review and meta-analysis. Dig. Dis. Sci. 61: 25-38.

MeSH terms